JP2008507261A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008507261A5 JP2008507261A5 JP2007519922A JP2007519922A JP2008507261A5 JP 2008507261 A5 JP2008507261 A5 JP 2008507261A5 JP 2007519922 A JP2007519922 A JP 2007519922A JP 2007519922 A JP2007519922 A JP 2007519922A JP 2008507261 A5 JP2008507261 A5 JP 2008507261A5
- Authority
- JP
- Japan
- Prior art keywords
- acid sequence
- polypeptide
- seq
- kit
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920001184 polypeptide Polymers 0.000 claims 30
- 102000004196 processed proteins & peptides Human genes 0.000 claims 30
- 108090000765 processed proteins & peptides Proteins 0.000 claims 30
- 108091033319 polynucleotide Proteins 0.000 claims 20
- 102000040430 polynucleotide Human genes 0.000 claims 20
- 239000002157 polynucleotide Substances 0.000 claims 20
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 19
- 125000003275 alpha amino acid group Chemical group 0.000 claims 19
- 150000007523 nucleic acids Chemical group 0.000 claims 19
- 150000001413 amino acids Chemical class 0.000 claims 16
- 238000000034 method Methods 0.000 claims 9
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 6
- 201000005202 lung cancer Diseases 0.000 claims 6
- 208000020816 lung neoplasm Diseases 0.000 claims 6
- 108091034117 Oligonucleotide Proteins 0.000 claims 2
- 210000004027 cell Anatomy 0.000 claims 2
- 210000001175 cerebrospinal fluid Anatomy 0.000 claims 2
- 230000000295 complement effect Effects 0.000 claims 2
- 238000001514 detection method Methods 0.000 claims 2
- 238000001943 fluorescence-activated cell sorting Methods 0.000 claims 2
- 238000003018 immunoassay Methods 0.000 claims 2
- 208000002154 non-small cell lung carcinoma Diseases 0.000 claims 2
- 238000003127 radioimmunoassay Methods 0.000 claims 2
- 210000001519 tissue Anatomy 0.000 claims 2
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 claims 2
- 108091093088 Amplicon Proteins 0.000 claims 1
- 206010061818 Disease progression Diseases 0.000 claims 1
- 238000002965 ELISA Methods 0.000 claims 1
- 206010036790 Productive cough Diseases 0.000 claims 1
- 206010041067 Small cell lung cancer Diseases 0.000 claims 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims 1
- 230000001154 acute effect Effects 0.000 claims 1
- 208000009956 adenocarcinoma Diseases 0.000 claims 1
- 238000003556 assay Methods 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 238000004113 cell culture Methods 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 230000005750 disease progression Effects 0.000 claims 1
- 238000005516 engineering process Methods 0.000 claims 1
- 230000005713 exacerbation Effects 0.000 claims 1
- 239000013604 expression vector Substances 0.000 claims 1
- 210000003608 fece Anatomy 0.000 claims 1
- 210000001035 gastrointestinal tract Anatomy 0.000 claims 1
- 238000002991 immunohistochemical analysis Methods 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 208000003849 large cell carcinoma Diseases 0.000 claims 1
- 210000004072 lung Anatomy 0.000 claims 1
- 210000004880 lymph fluid Anatomy 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000012544 monitoring process Methods 0.000 claims 1
- 210000000944 nerve tissue Anatomy 0.000 claims 1
- 210000000056 organ Anatomy 0.000 claims 1
- 210000002381 plasma Anatomy 0.000 claims 1
- 210000003296 saliva Anatomy 0.000 claims 1
- 230000028327 secretion Effects 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 210000003491 skin Anatomy 0.000 claims 1
- 208000000587 small cell lung carcinoma Diseases 0.000 claims 1
- 210000003802 sputum Anatomy 0.000 claims 1
- 208000024794 sputum Diseases 0.000 claims 1
- 206010041823 squamous cell carcinoma Diseases 0.000 claims 1
- 210000001138 tear Anatomy 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 210000002700 urine Anatomy 0.000 claims 1
- 239000013598 vector Substances 0.000 claims 1
- 238000001262 western blot Methods 0.000 claims 1
Applications Claiming Priority (32)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53912804P | 2004-01-27 | 2004-01-27 | |
| US53912904P | 2004-01-27 | 2004-01-27 | |
| US58981504P | 2004-07-22 | 2004-07-22 | |
| US60730704P | 2004-09-07 | 2004-09-07 | |
| US62065604P | 2004-10-22 | 2004-10-22 | |
| US62085304P | 2004-10-22 | 2004-10-22 | |
| US62097504P | 2004-10-22 | 2004-10-22 | |
| US62086804P | 2004-10-22 | 2004-10-22 | |
| US62091804P | 2004-10-22 | 2004-10-22 | |
| US62067704P | 2004-10-22 | 2004-10-22 | |
| US62087404P | 2004-10-22 | 2004-10-22 | |
| US62091604P | 2004-10-22 | 2004-10-22 | |
| US62100404P | 2004-10-22 | 2004-10-22 | |
| US62092404P | 2004-10-22 | 2004-10-22 | |
| US62091704P | 2004-10-22 | 2004-10-22 | |
| US62097404P | 2004-10-22 | 2004-10-22 | |
| US62113104P | 2004-10-25 | 2004-10-25 | |
| US62105304P | 2004-10-25 | 2004-10-25 | |
| US62818904P | 2004-11-17 | 2004-11-17 | |
| US62817804P | 2004-11-17 | 2004-11-17 | |
| US62813404P | 2004-11-17 | 2004-11-17 | |
| US62815604P | 2004-11-17 | 2004-11-17 | |
| US62825104P | 2004-11-17 | 2004-11-17 | |
| US62814504P | 2004-11-17 | 2004-11-17 | |
| US62811204P | 2004-11-17 | 2004-11-17 | |
| US62812304P | 2004-11-17 | 2004-11-17 | |
| US62816704P | 2004-11-17 | 2004-11-17 | |
| US62810104P | 2004-11-17 | 2004-11-17 | |
| US62811104P | 2004-11-17 | 2004-11-17 | |
| US63407504P | 2004-12-08 | 2004-12-08 | |
| US11/051,720 US7569662B2 (en) | 2004-01-27 | 2005-01-27 | Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer |
| PCT/IB2005/004037 WO2006131783A2 (en) | 2004-01-27 | 2005-01-27 | Polynucleotides, polypeptides, and diagnosing lung cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008507261A JP2008507261A (ja) | 2008-03-13 |
| JP2008507261A5 true JP2008507261A5 (enExample) | 2008-04-24 |
Family
ID=37450522
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007519922A Pending JP2008507261A (ja) | 2004-01-27 | 2005-01-27 | 肺癌診断のための新規のヌクレオチド配列およびアミノ酸配列、ならびにそのアッセイおよび使用方法 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1774046A4 (enExample) |
| JP (1) | JP2008507261A (enExample) |
| AU (1) | AU2005320352A1 (enExample) |
| CA (1) | CA2555509A1 (enExample) |
| WO (1) | WO2006131783A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2590751A1 (en) | 2004-12-13 | 2006-06-22 | Roy Rabindranauth Sooknanan | Polynucleotides and polypeptide sequences involved in the process of bone remodeling |
| EP4209510B1 (en) | 2008-12-09 | 2024-01-31 | F. Hoffmann-La Roche AG | Anti-pd-l1 antibodies and their use to enhance t-cell function |
| KR101403019B1 (ko) | 2013-02-25 | 2014-06-03 | 서울대학교산학협력단 | 폐암 진단용 마커 |
| CN114804550B (zh) * | 2022-06-10 | 2023-06-02 | 安徽新宇环保科技股份有限公司 | 一种基于神经网络模型的污水处理调控系统 |
| CN115894942B (zh) * | 2022-11-07 | 2024-01-12 | 同济大学 | 聚己内酯修饰的超支化梳型聚赖氨酸及应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6251386B1 (en) * | 1997-08-14 | 2001-06-26 | Novo Nordisk A/S | Antimicrobial composition containing a haloperoxidase, a hydrogen peroxide source, a halide source and an ammonium source |
| US20030170255A1 (en) * | 1999-06-30 | 2003-09-11 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
| EP1343886A2 (en) * | 2000-07-11 | 2003-09-17 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
| JP2005527180A (ja) * | 2001-04-18 | 2005-09-15 | プロテイン デザイン ラブス， インコーポレイテッド | 肺がんの診断方法、肺がんの修飾因子の組成及びスクリーニングの方法 |
| AU2002322280A1 (en) * | 2001-06-21 | 2003-01-21 | Millennium Pharmaceuticals, Inc. | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |
| WO2003097666A2 (en) * | 2002-05-16 | 2003-11-27 | Euro-Celtique, S.A. | Use of gastrin releasing peptide (grp) and its receptor in cancer screening |
-
2005
- 2005-01-27 AU AU2005320352A patent/AU2005320352A1/en not_active Abandoned
- 2005-01-27 JP JP2007519922A patent/JP2008507261A/ja active Pending
- 2005-01-27 EP EP05857765A patent/EP1774046A4/en not_active Withdrawn
- 2005-01-27 WO PCT/IB2005/004037 patent/WO2006131783A2/en not_active Ceased
- 2005-01-27 CA CA002555509A patent/CA2555509A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI585411B (zh) | 檢測膀胱癌之尿液標記物 | |
| US9249467B2 (en) | Bladder cancer detection composition, kit and associated methods | |
| CN110205378B (zh) | 一组脊柱结核血浆miRNA联合诊断标记物及其应用 | |
| KR102258096B1 (ko) | 혈청 엑소좀 긴 비번역 rna의 발현수준을 측정할 수 있는 제제를 포함하는 간암 진단용 키트 | |
| RU2525707C2 (ru) | Способы определения восприимчивости пациента к внутрибольничной инфекции и составления прогноза развития септического синдрома | |
| CN110229899B (zh) | 用于结直肠癌早期诊断或预后预测的血浆标记物组合 | |
| CN112094896A (zh) | 活动性结核病诊断标志物、试剂盒及其应用 | |
| JP2008510126A5 (enExample) | ||
| CN107868822B (zh) | 用于检测食道癌的组合物及其试剂盒和用途 | |
| Fang et al. | Plasma Exosomal CXCL7 is a Potential Biomarker for Lung Adenocarcinoma. | |
| CN104651522B (zh) | I型胶原α1链的新应用 | |
| JP2021166515A (ja) | 食道癌を検出するための組成物及びその使用 | |
| AU2005320352A2 (en) | Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer | |
| CN110129440B (zh) | 血液外泌体分子标志物及其在制备肝癌诊断产品中的应用 | |
| KR101670135B1 (ko) | 리포칼린 2 단백질에 특이적으로 결합하는 dna 앱타머 및 이의 용도 | |
| TW202122584A (zh) | 預測癌症預後之方法及其應用 | |
| AU2017254964B2 (en) | Urine markers for detection of bladder cancer | |
| JP2007525213A5 (enExample) | ||
| CN105483246A (zh) | 基因的差异表达在口腔癌诊断中的应用 | |
| WO2015137406A1 (ja) | 肺扁平上皮癌と肺腺癌の鑑別評価方法 | |
| JP7374196B2 (ja) | ヘリコバクターピロリ連関疾患に対する遺伝子マーカー | |
| JP2007520217A5 (enExample) | ||
| CN109971854B (zh) | 用于开发宫颈疾病的诊疗产品的靶分子 | |
| JP2007526763A5 (enExample) | ||
| CN117604111B (zh) | 用于小细胞肺癌诊断和预后判断的生物标志物及其应用 |